Aisner J, Wiernik P H, Pearl P
University of Maryland Cancer Center, Baltimore 21201.
J Clin Oncol. 1993 Mar;11(3):507-12. doi: 10.1200/JCO.1993.11.3.507.
This study attempted to determine the outcome of pregnancies in patients (or their partners) who were successfully treated for Hodgkin's disease and to assess the effect of treatment on the children of the treated parents.
A questionnaire was distributed to and personal interviews were conducted with patients who were of reproductive age at the time of treatment with consecutive protocols of radiotherapy, chemotherapy, or both. Those premenopausal patients (or the sexual partners of patients) who attempted to conceive after successful treatment constituted the study population. Fertility assessment was based only on those patients identified as desiring children.
Among 391 adult patients, 221 patients (104 females and 117 males) of reproductive age were interviewed. Before treatment, 63 of the 221 patients had 135 pregnancies, which resulted in 118 children, 11 spontaneous abortions, five elective abortions, and one stillborn. After treatment, 94 patients (43 females and 51 males) actively attempted conception; 35 females and 25 partners of male patients had 84 pregnancies, which resulted in 68 living children. Among the 84 pregnancies, there were one premature birth at 29 weeks, three spontaneous abortions, 11 elective abortions, and two stillborn: one at 32 weeks and one set of twins. The children have been observed for a median of 11 years (minimum follow up > 4.5 years). Of those patients who desired children, 35 of 43 females became pregnant, whereas only 25 of the 51 partners of male patients became pregnant. At least five male patients with low sperm counts apparently fathered children.
This study demonstrates that both men and women have the potential for fertility after treatment regardless of treatment modality. The partners of male patients who were treated with combined modality treatment had a lower frequency of pregnancy than did the female patients who attempted conception and their frequency of pregnancy was also lower than the general population. There was no apparent increase in complications of pregnancy, spontaneous abortions, or congenital abnormalities after treatment compared with pregnancies in this patient group before treatment or with pregnancies in the general population.
本研究试图确定接受过霍奇金淋巴瘤成功治疗的患者(或其伴侣)的妊娠结局,并评估治疗对接受治疗的父母所生孩子的影响。
向接受放疗、化疗或两者连续方案治疗时处于生育年龄的患者发放问卷并进行个人访谈。那些在成功治疗后试图怀孕的绝经前患者(或患者的性伴侣)构成了研究人群。生育力评估仅基于那些确定想要孩子的患者。
在391名成年患者中,对221名处于生育年龄的患者(104名女性和117名男性)进行了访谈。治疗前,221名患者中的63人有135次妊娠,产下118名儿童,11次自然流产,5次人工流产,1例死产。治疗后,94名患者(43名女性和51名男性)积极尝试受孕;35名女性和25名男性患者的伴侣有84次妊娠,产下68名存活儿童。在这84次妊娠中,有1例29周早产,3次自然流产,11次人工流产,2例死产:1例32周死产和1例双胞胎死产。这些孩子的中位观察时间为11年(最短随访时间>4.5年)。在那些想要孩子的患者中,43名女性中有35人怀孕,而51名男性患者的伴侣中只有25人怀孕。至少5名精子计数低的男性患者显然使配偶受孕。
本研究表明,无论治疗方式如何,男性和女性在治疗后都有生育能力。接受综合治疗的男性患者的伴侣怀孕频率低于试图受孕的女性患者,且其怀孕频率也低于一般人群。与该患者组治疗前的妊娠或一般人群的妊娠相比,治疗后妊娠并发症、自然流产或先天性异常没有明显增加。